Third-dose BNT162b2 vaccine is highly efficient at increasing anti-rbd sars-cov-2 igg titers in allo-hct recipients

L. Canti, S. Humblet-Baron, I. Desombere, P. Pannus, A. Henry, S. Servais, E. Willems, K. K. Arien, Y. Beguin, M. E. Goossens, A. Marchant, F. Baron

Research output: Contribution to journalConference abstract in journal

Original languageEnglish
Article numberP324
JournalBone Marrow Transplantation
Issue numberSuppl.1
Pages (from-to)280-280
Number of pages1
Publication statusPublished - 2022

Cite this